Sector portfolio · VC firm · United States

New Leaf Venture Partners' Biotech portfolio

New Leaf Venture Partners has backed 17 Biotech startups in rounds we track, $2.2B between them, shown by the stage each has reached. The best-funded is Intarcia Therapeutics.

17startups backed
4stages
$2.2Braised between them
Series C and laterbiggest stage

New Leaf Venture Partners's whole portfolioNew Leaf Venture Partners's profile

Segment by segment

Series C and later

8 startups · $906M raised

  1. Star TherapeuticsStar Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$325M
  2. Deciphera PharmaceuticalsDeciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.United States$127M
  3. ReViralReViral is a biotechnology company that develops and offers antiviral therapies for patients.United Kingdom$122M
  4. NeuroneticsNeuronetics is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders.United States$110M
  5. Presidio PharmaceuticalsPresidio Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery of small-molecule antiviral therapeutics.United States$109M
  6. KCKit CheckUnited States$48M
  7. Advanced Cell DiagnosticsAdvanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.United States$41M
  8. AiCureAiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.United States$25M

Stage not reported

4 startups · $371M raised

  1. True North TherapeuticsTrue North Therapeutics is a pioneering biotechnology company selectively inhibiting the Complement pathway for diseases.United States$142M
  2. ArvinasArvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics.United States$111M
  3. Principia BioPharmaPrincipia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.United States$90M
  4. ProteoGenixProteoGenix is a leading life sciences organization which provides services in molecular biology and immunology and in particular United States$28M

Series B

3 startups · $821M raised

  1. Wave Life SciencesWave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States$434M
  2. Passage BioPassage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.United States$380M
  3. KTKarus TherapeuticsKarus Therapeutics is a pharmaceutical research company that develops drugs to treat cancer and heart diseases.United Kingdom$7.6M

Series A

2 startups · $76M raised

  1. RenovacorNo mercado desde 2009, a Renovacor Tintas se diferencia pela fabricação de tintas e revestimentos acrílicos de qualidade que contaUnited States$41M
  2. CPConvergence PharmaceuticalsConvergence Pharmaceuticals is a biotechnology company focused on the development of novel analgesics for the treatment of chronic pain.United Kingdom$35M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names New Leaf Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like New Leaf Venture Partners?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.